Profile data is unavailable for this security.
About the company
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
- Revenue in USD (TTM)0.00
- Net income in USD-8.66m
- Incorporated2017
- Employees15.00
- LocationNeurosense Therapeutics Ltd11 Hamenofim St., Building BHERZLIYA 4672562IsraelISR
- Phone+972 97996183
- Websitehttps://www.neurosense-tx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promis Neurosciences Inc | 0.00 | -29.28m | 28.09m | 6.00 | -- | 3.35 | -- | -- | -18.62 | -18.62 | 0.00 | 4.27 | 0.00 | -- | -- | -- | -127.41 | -85.65 | -188.18 | -145.08 | -- | -- | -- | -3,184,250.00 | -- | -- | 0.00 | -- | -- | -- | 121.03 | -- | -- | -- |
| Passage Bio Inc | 0.00 | -45.26m | 28.29m | 60.00 | -- | 0.952 | -- | -- | -14.47 | -14.47 | 0.00 | 9.79 | 0.00 | -- | -- | 0.00 | -48.69 | -49.32 | -61.70 | -53.58 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 36.54 | -- | -54.23 | -- |
| Oncotelic Therapeutics Inc | 0.00 | -1.67m | 28.70m | 26.00 | -- | 3.06 | -- | -- | -0.0041 | -0.0041 | 0.00 | 0.0206 | 0.00 | -- | -- | 0.00 | -7.00 | -20.78 | -19.04 | -43.80 | -- | -- | -- | -1,590.30 | -- | -0.5591 | 0.632 | -- | -100.00 | -- | 42.76 | -- | -- | -- |
| AN2 Therapeutics Inc | 0.00 | -33.99m | 29.59m | 22.00 | -- | 0.4987 | -- | -- | -1.13 | -1.13 | 0.00 | 2.21 | 0.00 | -- | -- | 0.00 | -41.21 | -53.41 | -45.91 | -58.50 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 20.72 | -- | -- | -- |
| Outlook Therapeutics Inc | 1.51m | -62.42m | 29.74m | 17.00 | -- | -- | -- | 20.55 | -1.61 | -1.61 | 0.0432 | -0.5973 | 0.0635 | -- | -- | 88,548.23 | -263.36 | -240.08 | -- | -- | 70.78 | -- | -4,146.95 | -22,354.50 | 0.3067 | -200.54 | -- | -- | -- | -- | 17.17 | -- | -- | -- |
| Palatin Technologies Inc | 8.85m | -4.81m | 29.75m | 29.00 | -- | 41.40 | -- | 3.40 | -13.52 | -13.52 | 12.39 | 0.4073 | 1.47 | -- | -- | 305,087.90 | -79.90 | -79.95 | -- | -118.70 | 0.00 | 91.70 | -54.32 | -1,326.05 | -- | -- | 0.00 | -- | -100.00 | -- | 41.80 | -- | -- | -- |
| Dyadic International Inc | 3.34m | -7.35m | 30.14m | 6.00 | -- | 11.56 | -- | 9.02 | -0.2371 | -0.2371 | 0.1077 | 0.072 | 0.2974 | -- | 5.27 | 557,033.30 | -65.38 | -46.12 | -89.89 | -51.96 | 31.54 | 35.01 | -219.86 | -335.59 | -- | -34.44 | 0.6579 | -- | 20.58 | 15.77 | 14.51 | -- | -- | -- |
| Rein Therapeutics Inc | 0.00 | -58.89m | 30.23m | 11.00 | -- | 24.19 | -- | -- | -2.63 | -2.63 | 0.00 | 1.84 | 0.00 | -- | -- | 0.00 | -74.57 | -64.62 | -80.38 | -71.24 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -299.71 | -- | -- | -- |
| Neurosense Therapeutics Ltd | 0.00 | -8.66m | 30.29m | 15.00 | -- | -- | -- | -- | -0.361 | -0.361 | 0.00 | -0.0211 | 0.00 | -- | -- | 0.00 | -491.23 | -145.64 | -- | -198.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1.02 | -- | -15.59 | -- |
| Lantern Pharma Inc | 0.00 | -18.92m | 30.31m | 24.00 | -- | 3.35 | -- | -- | -1.75 | -1.75 | 0.00 | 0.8684 | 0.00 | -- | -- | 0.00 | -86.16 | -32.94 | -104.31 | -34.72 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -30.20 | -- | 17.11 | -- |
| Tempest Therapeutics Inc | 0.00 | -36.05m | 30.35m | 24.00 | -- | 1.69 | -- | -- | -10.40 | -10.40 | 0.00 | 1.43 | 0.00 | -- | -- | 0.00 | -141.49 | -63.01 | -215.46 | -80.57 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -41.88 | -- | 1.85 | -- |
| Harvard Apparatus Regenertv Tchnlgy Inc | 743.00k | -6.53m | 30.90m | 8.00 | -- | 19.56 | -- | 40.90 | -0.4029 | -0.4029 | 0.0459 | 0.0905 | 0.1891 | 9.21 | 371.50 | 92,875.00 | -166.09 | -292.39 | -227.59 | -1,068.06 | 16.29 | -- | -878.20 | -6,677.86 | 1.83 | -- | 0.00 | -- | 317.48 | -- | 14.30 | -- | -- | -- |
| VolitionRX Ltd | 1.47m | -22.88m | 31.03m | 85.00 | -- | -- | -- | 20.44 | -0.229 | -0.229 | 0.0147 | -0.316 | 0.1539 | -- | 4.74 | 17,317.88 | -241.07 | -122.29 | -- | -283.19 | -- | -- | -1,566.40 | -5,826.45 | -- | -15.03 | -- | -- | 59.10 | 135.30 | 23.65 | -- | 2.34 | -- |
| LAMY | 0.00 | 106.70k | 31.50m | -- | 25.51 | -- | 201.80 | -- | 0.0137 | 0.0137 | 0.00 | -0.0045 | 0.00 | -- | -- | -- | 763.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -67.39 | -- | 299.15 | -- | -- | -- |
| NextCure Inc | 0.00 | -58.01m | 31.76m | 43.00 | -- | 1.39 | -- | -- | -24.19 | -24.19 | 0.00 | 8.84 | 0.00 | -- | -- | 0.00 | -89.28 | -27.70 | -105.20 | -28.91 | -- | -- | -- | -1,336.59 | -- | -- | 0.00 | -- | -- | -- | 11.27 | -- | -32.45 | -- |
Data as of Feb 10 2026. Currency figures normalised to Neurosense Therapeutics Ltd's reporting currency: US Dollar USD
0.98%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Squarepoint OPS LLCas of 30 Sep 2025 | 95.38k | 0.32% |
| Morgan Stanley & Co. LLCas of 30 Sep 2025 | 41.40k | 0.14% |
| Meitav Mutual Funds Ltd.as of 30 Sep 2025 | 40.00k | 0.14% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 2025 | 25.00k | 0.08% |
| Two Sigma Investments LPas of 30 Sep 2025 | 21.09k | 0.07% |
| Commonwealth Equity Services LLCas of 30 Sep 2025 | 21.08k | 0.07% |
| UBS Securities LLCas of 31 Dec 2025 | 17.10k | 0.06% |
| Geode Capital Management LLCas of 30 Sep 2025 | 15.87k | 0.05% |
| UBS Switzerland AG (Investment Management)as of 31 Dec 2025 | 13.77k | 0.05% |
| SBI Securities Co., Ltd.as of 31 Dec 2025 | 1.46k | 0.01% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
